Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2011
05/18/2011CN102058601A Cefpodoxime composition for injection
05/18/2011CN102058596A Method for preparing chelerythrine medicament and application thereof in prevention and treatment of bacterial diseases of aquatic animals
05/18/2011CN102058589A 13,14-dihydroxyl matrine bactericide and application thereof
05/18/2011CN102058586A Ambroxol hydrochloride and amoxicillin compound sustained-release tablet
05/18/2011CN102058584A Preparation method of potassium clavulanate/microcrystalline cellulose composition
05/18/2011CN102058583A Ticarcillin sodium clavulanic acid potassium freeze-dried powder as well as preparation and preparation method thereof
05/18/2011CN102058577A Medicament compound adopting bicyclo-ethanol as active component and preparation thereof
05/18/2011CN102058568A Application of germacrone
05/18/2011CN102058561A Cefdinir capsule and preparation method thereof
05/18/2011CN102058559A Doxycycline hydrochloride effervescent tables for milk cows and preparation method thereof
05/18/2011CN102058553A Acyclovir sustained release tablet and preparation method thereof
05/18/2011CN102058547A Freeze-dried preparation
05/18/2011CN102058546A Freeze-drying preparation for recombinant swine alpha-interferon and preparation method and usage thereof
05/18/2011CN102058545A Meropenem freeze-dried preparation for injection and preparation method thereof
05/18/2011CN102058540A Azithromycin sustained-release microsphere and dry suspension, preparation method and application thereof
05/18/2011CN102058527A Preparation method and low-temperature continuous stirring ultrafiltration device for anti-tumor and anti-infection allicin injection
05/18/2011CN102058525A Lamivudine injection and preparation method thereof
05/18/2011CN102058522A Peramivir injection and preparation method thereof
05/18/2011CN102058521A Injection preparation containing Entecavir serving as active ingredient
05/18/2011CN102058519A Voriconazole slow-release suppository and preparation method thereof
05/18/2011CN102058507A Health toothpaste prepared from multiple valuable Chinese medicinal materials for preventing and treating oral diseases
05/18/2011CN102058506A Toothpaste for treating tooth shake and toothache, firming teeth and blacking hairs
05/18/2011CN102057960A Traditional Chinese medicine powder for treating white plague and method for treating white plague
05/18/2011CN102057958A Mosquito repellent incense with combined functions for preventing children from catching cold and repelling mosquitoes and preparation method thereof
05/18/2011CN101856335B Azithromycin composite freeze-dried powder for injection
05/18/2011CN101843589B Ceftizoxime sodium composition sterile powder for injection
05/18/2011CN101780034B Cefathiamidine suspension and novel application thereof
05/18/2011CN101708187B Dry powder preparation for preventing and controlling saprolegniasis of aquatic animals and preparation method thereof
05/18/2011CN101697959B Potassium sodium dehydroandrographolide succinate sodium chloride injection
05/18/2011CN101693040B Medicament for treating onychomycosis and preparation method thereof
05/18/2011CN101690791B Traditional Chinese medicine for treating epidemic encephalitis B
05/18/2011CN101690783B External medicine for curing onychomycosis
05/18/2011CN101632669B Method of using diketopiperazines and composition containing them
05/18/2011CN101585836B Novel method for preparing Nevirapine
05/18/2011CN101569628B Cefmenoxime hydrochloride composition powder injection and manufacturing method thereof
05/18/2011CN101559138B Externally applied medicament for treating porcine foot-and-mouth disease and PRRS
05/18/2011CN101550138B Mercapto azacycloalkyl acidamide alcohol substituted penem derivates
05/18/2011CN101537060B Medicine for treating AIDS
05/18/2011CN101486685B Microwave extracting process for 4(3H) quinazolone in dyers woad leaf
05/18/2011CN101412720B Carbapenem compound containing mercapto nitrogen heterocyclic vinyl
05/18/2011CN101406652B Chinese medicine capsule for treating tinea corporis
05/18/2011CN101401787B Ceftiofur long-acting injection and preparation method thereof
05/18/2011CN101385745B Agent which is anti-adhesive in relation to the pathogenic flora of the skin
05/18/2011CN101378748B Pharmaceutical composition having a ruthenium oxalato compound and method of using the same
05/18/2011CN101372489B Carbapenem derivative containing sulfhydryl pyrrolidine formamide benzyl
05/18/2011CN101367816B Carbpenem derivants
05/18/2011CN101366881B Traditional Chinese medicine for treating acute infectious conjunctivitis
05/18/2011CN101362761B Carbapenem antibiotic containing sulfhydryl piperidine
05/18/2011CN101357918B Penem derivative containing isothioureido sulfhydryl pyrrolidine
05/18/2011CN101357888B Method for preparing ferrous rosmarinci acid and magnesian rosmarinci acid and antibacterial activity application thereof
05/18/2011CN101338004B Sterilization polymer and preparation process thereof
05/18/2011CN101333218B Formamide alkylbenzene substituted mercapto pyrrolidine carbapenem compounds
05/18/2011CN101328207B Citrus fruit fly antibacterial peptide, preparation and use thereof
05/18/2011CN101328181B Novel penem compounds
05/18/2011CN101274050B Application of rhizome of Common Burreed in preparation of medicament for curing virosis
05/18/2011CN101209351B Ankara vaccinia virus genetic engineering vaccine for pig replication and respiration complex
05/18/2011CN101190883B Novel compound with antiviral activity
05/18/2011CN101186611B Pyrroline-2-one derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application
05/18/2011CN101143871B Cephalosporin derivative
05/18/2011CN101112619B 疫苗组合物 Vaccine compositions
05/18/2011CN101084985B separation and identification of highly effective antibiotic anti-oxidant active part of glycyrrhiza
05/18/2011CN101027066B Amphiphilic polynorbornene derivatives and methods of using the same
05/18/2011CN101014320B Composition of treatment of endobronchial infections
05/17/2011USRE42375 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
05/17/2011US7943757 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
05/17/2011US7943636 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
05/17/2011US7943635 Farnesyl-protein transferase inhibitors
05/17/2011US7943627 2,4-diaminopyrimidine derivatives
05/17/2011US7943610 Pyrazolopyridine-1,4-diamines and analogs thereof
05/17/2011US7943595 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
05/17/2011US7943574 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
05/17/2011US7943375 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
05/17/2011US7943316 Immunostimulatory oligonucleotides and uses thereof
05/17/2011US7943153 Vaccines for Mycoplasma bovis and methods of use
05/17/2011US7943152 By injection into the eyelid or conjunctiva to reduce secretions from the meibomian glands; nonsurgical; antisecretory agents
05/17/2011US7943125 Attenuated gram negative bacteria
05/17/2011US7942958 Composite biocidal particles
05/17/2011CA2502785C Neisserial mutant strain lacking expression of a glycosyltransferase
05/17/2011CA2470365C 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
05/17/2011CA2462710C Polypeptide antigen forming a mimetic structure of the gp41 intermediate state
05/17/2011CA2451521C Use of poly-glu, tyr for neuroprotective therapy
05/17/2011CA2411642C Use of ingenanes for the activation of latent virus infection
05/17/2011CA2401385C Protein matrix materials, devices and methods of making and using thereof
05/17/2011CA2397194C Alpha v integrin receptor antagonists
05/17/2011CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
05/17/2011CA2228221C Papillomavirus polyprotein constructs
05/12/2011WO2011057262A2 Treatment of infections with tp receptor antagonists
05/12/2011WO2011057215A1 Novel inhibitors of hepatitis c virus replication
05/12/2011WO2011057169A2 Improved silver oxide formulations
05/12/2011WO2011057160A2 Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120
05/12/2011WO2011057145A2 Imidazo[1,2-a] pyridine compounds, synthesis thereof, and methods of using same
05/12/2011WO2011056899A2 Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
05/12/2011WO2011056652A1 Imidazole derivatives as ido inhibitors
05/12/2011WO2011056650A2 Methods and compositions for treating and preventing viral infections
05/12/2011WO2011056630A2 Small molecule inhibitors of hepatitis c virus
05/12/2011WO2011056545A2 Antimicrobial ionic liquids
05/12/2011WO2011056486A2 Devices, methods, and composition for controlling infections
05/12/2011WO2011056168A1 Antimicrobial compositions and methods
05/12/2011WO2011055979A2 Antiviral composition containing an aleurites fordii or daphne kiusiana extract or a fraction thereof as an active ingredient
05/12/2011WO2011055931A2 Composition for preventing or treating diseases caused by influenza viruses